Going by the price action in some stocks in the recent past, it seems that the meme stock euphoria is at its early stage. Potential rate cuts to boost economic growth will likely be a perfect recipe for a full-fledged meme stock season. It’s, therefore, a good time to look at some short-squeeze stocks to buy for quick returns in the blink of an eye.I always prefer to keep expectations on a base-case scenario. Therefore, I expect a 50% rally in the short-squeeze stocks discussed. However, a 2x or 3x rally in ...

This beaten-down pot stock may have a lot of upside only if the U.S. marijuana market opens up for business.Thus far, 2024 has been an exceptional year for Aurora Cannabis (ACB) stock. Up more than 40%, it's been generating some impressive returns for investors. And recent developments involving rescheduling marijuana in the U.S. has gotten investors even more bullish about the stock and its long-term prospects.Could the Biden Administration's latest move, to reclassify marijuana as a Schedule III substance ...

Among the emerging industries that have captured the attention of investors is the cannabis sector. The cannabis industry has experienced remarkable growth, giving rise to a new breed of top cannabis stocks to buy for investments in May.Although the results so far from the cannabis industry have disappointed many investors, I feel that the long-term prospects remain promising. While the initial hype and optimism surrounding the legalization of cannabis may have led to unrealistic expectations, it is importa ...

NASDAQ | TSX: ACBCanada's Leading Medical Cannabis Company Launches Premium Products Redefining Patient CareEDMONTON, AB, May 8, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) the Canadian based leading global medical cannabis company, is proud to announce the arrival of Aurora branded medical cannabis products to the New Zealand market. This new line of premium dried flowers represents a significant milestone in medical cannabis accessibility in New Zealand, an emerging market poised for ...

Aurora Cannabis Inc. (ACB) shares soared 46% in the last trading session to close at $9.23. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 46.6% gain over the past four weeks.The sharp upsurge in Aurora's shares can be attributed to the DEA's reported decision to reclassify marijuana from Schedule I (reserved for drugs with a high potential for abuse) to Schedule III (reserved for drugs with a moderate to low potential for physi ...

The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.The Drug Enforcement Administration's (DEA) proposal would recognise the drug's medical properties and acknowledge it has less potential for abuse than other dangerous substances. However the proposal, which still must be reviewed by the White House, would not legalise cannabis outright for recreational use.Marijuana is currently classified in the US as a "schedule ...

Cannabis stocks soared nearly across the board this afternoon on news that President Joe Biden’s administration is moving to reschedule marijuana as a Schedule III substance, a less severe designation than its prior Schedule I classification. Indeed, acting on a review from the Department of Health and Human Substances, the U.S. Drug Enforcement Administration (DEA) and U.S. Justice Department may recategorize cannabis as early as this week. A move to Schedule III would yield major benefits to both the lega ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

The new dried flowers, including Black Jelly, Chemango Kush, and Moon Berry, are proprietary cultivars cultivated exclusively by Aurora. Vespera, a previously existing proprietary cultivar, is also set for relaunch under the Aurora brand. These products mark a significant step forward for MedReleaf Australia as they continue to expand their offerings under the Aurora brand.  The dried flower products are available now in four 10g formats including: Aurora Moon Berry T9/C13 Balanced Aurora Black Jelly T28 ...

Ahead of the Curve: Leading Canadian Cannabis Stocks for Early 2024The global cannabis industry and top marijuana stocks are poised for significant growth, driven by increasing legalization and medical use. Furthermore, experts predict a compound annual growth rate of over 20% for the next decade. Consequently, this expansion benefits top Canadian companies such as Canopy Growth, Aurora Cannabis, and Aphria. These firms lead the market in innovation and distribution. Therefore, investors should closely moni ...